Determinan Kesediaan Masyarakat menerima Vaksinasi Covid-19 di Sulawesi Tengah
https://doi.org/10.33860/jik.v15i1.430
Keywords:
Determinan kesediaan, vaksinasi, Covid-19Abstract
Tujuan penelitian untuk mengetahui determinan kesediaan masyarakat menerima vaksinasi Covid-19 di Sulawesi Tengah. Penelitian deskriptif analitik desain cross sectional pada Januari tahun 2021. Survei online masyarakat di Sulawesi Tengah dengan 266 orang responden berusia 18 tahun ke atas. Pengumpulan data secara accidental sampling melalui https://ee.kobotoolbox.org/x/aSWgcPdw dan dianalisis menggunakan SPSS 22,0 uji chi square dan regresi logistik kemaknaan p-value 0,05%. Hasil penelitian menunjukkan responden berjenis kelamin perempuan 68,0%, berumur 20-40 tahun 31,2%, berpendidikan tinggi 39,5%. Status pelajar/mahasiswa 33,5% dan aparatur sipil negara sebanyak 23,3%. Status menikah 51,9%, beragama Islam 80,8%, suku bugis 24,4% dan berada di daerah perkotaan 52,6%. Responden yang memiliki kartu badan penyelenggara jaminan sosial 80,5%. Perilaku pencegahan Covid-19 meliputi; penggunaan masker 99,6% menjaga jarak 95,9% menghindari kerumunan 95,5% dan mencuci tangan menggunakan sabun pada air mengalir 96,2%. Responden yang bersedia menerima vaksinasi Covid-19 sebesar 35,3%. Faktor yang mempengaruhi kesediaan masyarakat Sulawesi Tengah menerima vaksinasi adalah faktor umur, tingkat pendidikan, pekerjaan, status pernikahan, agama dan suku. Determinan kesediaan masyarakat menerima Vaksinasi Covid-19 adalah umur dan agama. Kesimpulan; Responden yang bersedia menerima vaksinasi Covid-19 sebesar 35,3% dengan determinan umur dan agama. Disarankan agar sosialisasi untuk divaksinasi Covid-19 fokus pada orang dengan kelompok umur ≤40 tahun dan beragama Islam. Sosialisasi vaksinasi Covid-19 melalui televisi dan media sosial facebook dan Instagram oleh satgas Covid-19, Badan Pengawas Obat dan Makanan dan Kementerian Kesehatan.
Author Biographies
Fahmi Hafid, Poltekkes Kemenkes Palu
Kadar Ramadhan, Poltekkes Kemenkes Palu
Taqwin Taqwin, Poltekkes Kemenkes Palu
References
Ko SC. Herd immunity, vaccine development and BCG effects in COVID-19. J Intern Med Taiwan [Internet]. 2020;31(4):254–61. Available from: http://www.tsim.org.tw/journal/jour31-4/04.PDF
Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine [Internet]. 2020 Oct;38(45):7002–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0264410X20312019
Pasaribu TAA. Persepsi Masyarakat Tentang Covid 19. 2021; Available from: https://osf.io/qbjmt
Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine [Internet]. 2020 Sep;38(42):6500–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0264410X20310847
Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol [Internet]. 2020 Apr 22;35(4):325–30. Available from: http://link.springer.com/10.1007/s10654-020-00634-3
Ding Y, Du X, Li Q, Zhang M, Zhang Q, Tan X, et al. Risk perception of coronavirus disease 2019 (COVID-19) and its related factors among college students in China during quarantine. Yi S, editor. PLoS One [Internet]. 2020 Aug 13;15(8):e0237626. Available from: https://dx.plos.org/10.1371/journal.pone.0237626
Zhu F-C, Guan X-H, Li Y-H, Huang J-Y, Jiang T, Hou L-H, et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet [Internet]. 2020 Aug;396(10249):479–88. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673620316056
Iserson, V K. SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward. Cambridge Q Healthc Ethics [Internet]. 2021 Jan 5;30(1):59–68. Available from: https://www.cambridge.org/core/product/identifier/S096318012000047X/type/journal_article
Danchin M, Biezen R, Manski-Nankervis J-A, Kaufman J, Leask J. Preparing the public for COVID-19 vaccines: How can general practitioners build vaccine confidence and optimise uptake for themselves and their patients? Aust J Gen Pract [Internet]. 2020 Oct 1;49(10):625–9. Available from: https://www1.racgp.org.au/ajgp/2020/october/preparing-the-public-for-covid-19-vaccines
Febriyanti N, Choliq MI, Mukti AW. Hubungan Tingkat Pengetahuan dan Kesediaan Vaksinasi Covid-19 pada Warga Kelurahan Dukuh Menanggal Kota Surabaya. SNHRP [Internet]. 2021; Available from: https://snhrp.unipasby.ac.id/prosiding/index.php/snhrp/article/view/168
Chew P. COVID-19 Vaccination Education App(1). In: SSRN Electronic Journal [Internet]. papers.ssrn.com; 2021. Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3842490
Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. J Multidiscip Healthc. 2020;(13):1657–63.
Guhlincozzi AR, Lotfata A. Travel distance to flu and COVID-19 vaccination sites for people with disabilities and age 65 and older, Chicago metropolitan area. J Heal Res [Internet]. 2021 May 13;ahead-of-p(ahead-of-print). Available from: https://www.emerald.com/insight/content/doi/10.1108/JHR-03-2021-0196/full/html
Sultana F, Mahmud Reza H. Are SAARC countries prepared to combat COVID-19 to save young, working-age population? AIMS Public Heal. 2020;7(3):440–9.
Malmgren J, Guo B, Kaplan HG. Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State March—August 2020. Borrow R, editor. PLoS One [Internet]. 2021 Mar 24;16(3):e0243042. Available from: https://dx.plos.org/10.1371/journal.pone.0243042
MacIntyre CR, Cauchemez S, Dwyer DE, Seale H, Cheung P, Browne G, et al. Face Mask Use and Control of Respiratory Virus Transmission in Households. Emerg Infect Dis [Internet]. 2009 Feb;15(2):233–41. Available from: http://wwwnc.cdc.gov/eid/article/15/2/08-1167_intro.htm
Wong SH, Teoh JYC, Leung C-H, Wu WKK, Yip BHK, Wong MCS, et al. COVID-19 and Public Interest in Face Mask Use. Am J Respir Crit Care Med [Internet]. 2020 Aug 1;202(3):453–5. Available from: https://www.atsjournals.org/doi/10.1164/rccm.202004-1188LE
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med [Internet]. 2020 Mar 19;382(12):1177–9. Available from: http://www.nejm.org/doi/10.1056/NEJMc2001737
Pasion R, Paiva TO, Fernandes C, Barbosa F. The AGE Effect on Protective Behaviors During the COVID-19 Outbreak: Sociodemographic, Perceptions and Psychological Accounts. Front Psychol [Internet]. 2020 Oct 16;11. Available from: https://www.frontiersin.org/article/10.3389/fpsyg.2020.561785/full
Monod M, Blenkinsop A, Xi X, Hebert D, Bershan S, Tietze S, et al. Age groups that sustain resurging COVID-19 epidemics in the United States. Science (80- ) [Internet]. 2021 Mar 26;371(6536):eabe8372. Available from: https://www.sciencemag.org/lookup/doi/10.1126/science.abe8372
Sadarangani M, Abu Raya B, Conway JM, Iyaniwura SA, Falcao RC, Colijn C, et al. Importance of COVID-19 vaccine efficacy in older age groups. Vaccine [Internet]. 2021 Apr;39(15):2020–3. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0264410X21002887
Husni H, Bisri H, Tanto Aljauharie Tantowie SSR, Azis A. Religious Community Responses to COVID-19: Case Study on Muslim Small Community. Int J Psychosoc Rehabil [Internet]. 2020;24(8):10439–46. Available from: http://digilib.uinsgd.ac.id/id/eprint/31190
Jardine R, Wright J, Samad Z, Bhutta ZA. Analysis of covid-19 burden, epidemiology and mitigation strategies in muslim majority countries. East Mediterr Heal J. 2020;26(10):1173–83.
Pabbajah M, Said NM, Faisal, Taufiq Hidayat Pabbajah M, Jubba H, Juhansar. Deauthorization of the religious leader role in countering covid- 19: Perceptions and responses of muslim societies on the ulama’s policies in indonesia. Int J Criminol Sociol. 2020;9:262–73.
Brown S, Brown T, Cederna PS, Rohrich RJ. The Race for a COVID-19 Vaccine: Current Trials, Novel Technologies, and Future Directions. Plast Reconstr Surg - Glob Open. 2020;1–14.
Hillard PJA. COVID, Science, Vaccines, and Public Trust. J Pediatr Adolesc Gynecol [Internet]. 2020 Dec;33(6):617–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1083318820303533
Basch CH, Hillyer GC, Zagnit EA, Basch CE. YouTube coverage of COVID-19 vaccine development: implications for awareness and uptake. Hum Vaccin Immunother [Internet]. 2020 Nov 1;16(11):2582–5. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2020.1790280
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med [Internet]. 2020;2603–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33301246
Hwang J. Health Information Sources and the Influenza Vaccination: The Mediating Roles of Perceived Vaccine Efficacy and Safety. J Health Commun [Internet]. 2020 Sep 1;25(9):727–35. Available from: https://www.tandfonline.com/doi/full/10.1080/10810730.2020.1840675
Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Glob Heal [Internet]. 2020 Oct;5(10):e004206. Available from: https://gh.bmj.com/lookup/doi/10.1136/bmjgh-2020-004206
Horton R. Offline: Preparing for a vaccine against COVID-19. Lancet [Internet]. 2020 Jul;396(10246):226. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673620316366
Al Awaidy ST, Khamis F. Preparing the Community for a Vaccine Against COVID-19. Oman Med J [Internet]. 2020 Nov 15;35(6):e193–e193. Available from: http://omjournal.org/articleDetails.aspx?coType=1&aId=2774
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.
Poltekita : Jurnal Ilmu Kesehatan is licensed under a Creative Commons Attribution-Share Alike 4.0 International License
You are free to:
- Share, copy and redistribute the material in any medium or format
- Adapt, remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
